Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study concluded that TrichoScan is error-prone in its current form and overestimates certain hair growth parameters, with results not aligning with clinical severity of alopecia.

This letter discusses potential hair loss effects of Hedgehog inhibitors but presents no new clinical findings, urging further exploration of this possible class effect.

In this study, researchers in South India observed that dermoscopic features like hair diameter diversity and miniaturized hair were common in female pattern hair loss, with yellow dots and honeycombing indicating more advanced stages, highlighting dermoscopy's utility in diagnosing and differentiating FPHL early.

This chapter reviews the causes, clinical characteristics, and modern management of male and female pattern hair loss but reports no new clinical results.

This abstract discusses the effects of androgenetic alopecia on men's and women's quality of life but reports no new research findings.

This article reviews female pattern hair loss in women, highlighting its characteristics, treatment options, and the need to differentiate it from other hair loss conditions, and reports no new clinical results.

This case report describes a 52-year-old black woman with diffuse scalp swelling and thinning hair attributed to a large increase in the thickness of scalp subcutaneous fatty tissue.

This article discusses the presence of dirty dots as a normal trichoscopic finding in children, noting they are not observed in adults or other age groups, and reports no new results.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

This case report describes a 45-year-old woman with diffuse nonscarring alopecia characterized by hair thinning, increased catagen/telogen follicles, and mild inflammatory infiltrate, highlighting the diagnostic findings via scalp dermoscopy and biopsy.

This review describes the typical presentation of female pattern hair loss, noting that it often involves diffuse thinning on the scalp's top and crown without leading to total hair loss.

This article discusses COVID-19-induced hair loss, noting that both the infection and related stress may contribute to diffuse thinning and androgenic alopecia, and emphasizes the importance of dermatological evaluation.

This study found that UV stabilizers must diffuse uniformly and in high uptake levels throughout hair fibers during humidification cycles to effectively prevent photo-oxidative degradation.

This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.

This study found that age-related hair thinning in Caucasian women over 50 involves significant structural changes within the hair follicle, suggesting an "aged hair program" rather than just producing thinner hairs.

This review describes lichen planopilaris diffuse pattern and recommends topical corticosteroids as a first-line treatment, but reports no new clinical results.

This study reports that telogen effluvium, a type of hair thinning, commonly follows SARS-CoV-2 infection after 1 to 3 months, possibly due to stress, inflammation, or direct viral impact on hair follicles.

This report suggests that clinically inapparent sweat gland tumors might cause scalp hair loss, as seen in a case of a 57-year-old woman with progressive hair thinning.

This case study observed that discontinuing risperidone reduced elevated prolactin levels and improved hair thinning in a 77-year-old woman, suggesting risperidone-associated telogen effluvium as a consideration in similar cases.

In this study, researchers found that patients with non-scar alopecia exhibited thinner hair sacs and root sheaths compared to a control group, with significant thinning observed in cases of alopecia areata.

In this case report, a 16-year-old girl with adolescent androgenetic alopecia showed visible improvement in hair density after 2 years of treatment with 3% topical minoxidil, despite a family history of the condition and normal hormone levels.

This abstract provides only publication and correspondence details; it does not present any study findings or results.

In this case report, a 7-year-old girl with alopecia areata showed approximately 80% hair regrowth and resolved scalp symptoms after four months of individualized homeopathic treatment, maintaining clinical improvement with minimal relapse over more than a year.

This article presents a case history of hair loss in a 16-year-old girl and provides no new research findings.

The report suggests a possible link between hair loss and hidden scalp tumors but states more evidence is needed to confirm this.

This case study reported on a 72-year-old woman initially diagnosed with inflammatory alopecia, later identified as having angiosarcoma of the scalp, revealing the importance of considering unexpected malignancies during evaluation of suspected inflammatory alopecia cases.

This case report describes a 76-year-old woman with advanced female androgenetic alopecia experiencing improved hair volume and regrowth following five months of individualized homeopathic treatment at Dr. Batra’s® clinic.

This study reports that spironolactone, a potassium-sparing diuretic with antiandrogenic activity, effectively improves hair density, reduces shedding, and stabilizes symptoms in female pattern hair loss, though symptoms often recur after discontinuation, suggesting the need for sustained therapy.

This study reports that spironolactone has shown effectiveness in improving hair density and reducing shedding in female pattern hair loss, particularly for women with hyperandrogenism, though benefits often diminish after stopping treatment.

The authors reported a case of significant scalp edema accompanying lichen planopilaris in a middle-aged woman, suggesting a potential new variant of edematous scalp conditions as a reaction to scarring alopecia.